Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AKR1C1-IN-1

AKR1C1-IN-1 is a potent and selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1), exhibiting a Ki value of 4 nM. This compound is a valuable research tool for investigating AKR1C1's role in steroid metabolism and hormone-dependent cancers in both cellular and biochemical assays.

Product Specifications

CAS Number

4906-68-7

Product Name Alternative

Progesterone, inhibit, Inhibitor, AKR1C4, AKR1C2, AKR1C3, AKR1C1, AKR1C1 IN 1, AKR1C1IN1, AKR-1C1-IN-1, AKR1C1-IN-1

Field of Research

Metabolism Research

Purity

98.62% (May vary between batches)

Solubility

DMSO:27.5 mg/mL (93.82 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.82 mM)

Smiles

OC (=O) c1cc (cc (Br) c1O) -c1ccccc1

Molecular Formula

C13H9BrO3

Molecular Weight

293.12

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ZNF98 3'UTR Lenti-reporter-Luc Vector
51923081 1.0 µg

ZNF98 3'UTR Lenti-reporter-Luc Vector

Sign In for Pricing
View Details
(aR) -3-Bromo-a-methyl-4-pyridinemethanol
OR1034855-01 100 mg

(aR) -3-Bromo-a-methyl-4-pyridinemethanol

Sign In for Pricing
View Details
(aR) -3-Bromo-a-methyl-4-pyridinemethanol
OR1034855-02 250 mg

(aR) -3-Bromo-a-methyl-4-pyridinemethanol

Sign In for Pricing
View Details
(aR) -3-Bromo-a-methyl-4-pyridinemethanol
OR1034855-03 500 mg

(aR) -3-Bromo-a-methyl-4-pyridinemethanol

Sign In for Pricing
View Details
(aR) -3-Bromo-a-methyl-4-pyridinemethanol
OR1034855-04 1 g

(aR) -3-Bromo-a-methyl-4-pyridinemethanol

Sign In for Pricing
View Details
MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (APC)
168822-AF-APC 100 µL

MART-1 (Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA, Melan-A) (APC)

Sign In for Pricing
View Details